Page last updated: 2024-10-22

acetohydroxamic acid and Leukemia, Myeloid

acetohydroxamic acid has been researched along with Leukemia, Myeloid in 1 studies

acetohydroxamic acid: urease inhibitor
oxime : Compounds of structure R2C=NOH derived from condensation of aldehydes or ketones with hydroxylamine. Oximes from aldehydes may be called aldoximes; those from ketones may be called ketoximes.
N-hydroxyacetimidic acid : A carbohydroximic acid consisting of acetimidic acid having a hydroxy group attached to the imide nitrogen.
acetohydroxamic acid : A member of the class of acetohydroxamic acids that is acetamide in which one of the amino hydrogens has been replaced by a hydroxy group.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research Excerpts

ExcerptRelevanceReference
"Acetohydroxamic acid has been identified, by paper chromatography, in the blood of three patients with chronic myelogenous leukemia on hydroxyurea therapy."3.64HYDROXYUREA: MECHANISM OF ACTION. ( CARBONE, PP; FISHBEIN, WN, 1963)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FISHBEIN, WN1
CARBONE, PP1

Other Studies

1 other study available for acetohydroxamic acid and Leukemia, Myeloid

ArticleYear
HYDROXYUREA: MECHANISM OF ACTION.
    Science (New York, N.Y.), 1963, Nov-22, Volume: 142, Issue:3595

    Topics: Blood Chemical Analysis; Chromatography; Humans; Hydroxamic Acids; Hydroxyurea; Leukemia; Leukemia,

1963